DBV Technologies to sell 4.27 million ADSs in initial public offering

Citigroup, Leerink are bookrunners; Bryan, Garnier and Trout to assist

By Devika Patel

Knoxville, Tenn., Oct. 15 – DBV Technologies SA will sell 4,277,826 American Depositary Shares representing 2,138,913 ordinary shares in its initial public sale with a greenshoe option of 320,836 additional ordinary shares in the form of 641,672 ADS, according to a Form F-1/A filed Wednesday with the Securities and Exchange Commission. The deal was announced Sept. 22.

Citigroup and Leerink Partners are the joint bookrunners; Bryan, Garnier & Co. is the lead manager and Trout Capital is the co-manager.

The company also plans to sell 534,728 ordinary shares in a concurrent registered private placement with a greenshoe of 80,209 additional ordinary shares.

The public sale and private placement are conditional upon each other.

Proceeds will be used for development, expanding manufacturing infrastructure and general corporate purposes.

The biopharmaceutical company is based in Bagneux, France. The company has applied to list the ADSs on the Nasdaq under the symbol “DBVT.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.